• Agenda
    • Get Involved
    • Attendee FAQs
    • Programs
    • Interactive Discussions
    • Short Courses
    • Plenary Keynotes
    • Speaker Biographies
    • Attendees
    • Networking
    • Archives
  • Sponsor/Exhibitor
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Current Exhibitors - Floorplan
    • Exhibit Services Schedule
    • Exhibitor Prospectus
    • Lead Generation Opportunities
    • FAQs
    • Sponsor & Exhibitor Portal
  • Media
    • Media Partners
    • Media Gallery
    • Downloads
  • Travel
    • Travel Information
    • Health and Safety
  • Posters
    • Poster Information
    • Poster Titles
  • Register
    • Individual Pricing
    • Group Pricing
    • On Demand Pricing
    • Flexible Registration Policy
Discovery on Target Mobile
sponsorship-exhibit-banner
Demographics Sponsors Opportunities Exhibits Lead Gen FAQ

Sponsors

Premier Sponsor

  • OmniAb

Corporate Sponsors

  •  Collaborative Drug Discovery
  • dot212600-cellecta-inc-companyLogo-WebReady
  • charles_river_Tagline
  • CuriBio
  • FluidicAnalytics

GENOVAC

  •             Horizon_Discovery_2022
  • Integral-Molecular_NEW
  • Laxai_new
  • Multispan_new_2020
  • Orbit_Discovery
  •   ReactionBiology_2021
  • Specifica_NEW
  • TWIST-Bioscience
  • Wuxi-Apptec

Corporate Support Sponsors

  •  Agilent_New_Tagline
  • Altis
  • Aspen_Biosciences
  • Biosensing_Instrument
  • BPS-Bioscience
  • Carterra
  • Curia
  • Domainex_new

  • ImmunoPrecise_New
  • ION_Biosciences
  • Medicilon
  • Nanome
  • NCARDIA
  • NovAlix
  • ONCO-design-Biotechnology
  • ProteoGenix
  • Sai
  • TargetMol


Outlook YouTube Facebook LinkedIn Twitter
#BostonDOT22


Submit a Speaker Proposal
Register Early for Maximum Savings
Health and Safety
Register
2022 Programs
Purchase On-Demand
View All Sponsors
View Media Partners

October 17

Emerging Immune Modulation Strategies


October 18-19

PROTACs and Molecular Glues
– Part 1

Target Identification and Validation
– Part 1

Targeting RNA

Small Molecule Immuno-Oncology Targets

GPCR-Based Drug Discovery

Antibodies Against Membrane Protein Targets – Part 1

Targeting KRAS and Other Small G Proteins

Artificial Intelligence in Drug Discovery – Part 1NEW


October 19-20

PROTACs and Molecular Glues
– Part 2

Target Identification and Validation
– Part 2

New Antivirals NEW

NASH and Fibrosis

Neurodegeneration Targets NEW

Antibodies Against Membrane Protein Targets – Part 2

Drug Lead Generation Strategies

Artificial Intelligence in Drug Discovery – Part 2 NEW

CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Genomics

Healthcare

IT & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy